Kymera Therapeutics, Inc.
KYMR
$24.12
$1.727.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 488.74M | 549.97M | 509.95M | 520.54M | 374.88M |
| Total Receivables | 947.00K | 1.32M | 1.70M | 2.03M | 18.76M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 20.58M | 17.43M | 13.75M | 14.68M | 11.67M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 510.27M | 568.72M | 525.41M | 537.25M | 405.32M |
|
|
|||||
| Total Current Assets | 510.27M | 568.72M | 525.41M | 537.25M | 405.32M |
| Net Property, Plant & Equipment | 97.86M | 99.31M | 100.44M | 98.67M | 101.08M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.74M | 5.78M | 7.73M | 7.94M | 7.93M |
| Total Assets | 978.04M | 1.03B | 826.02M | 868.25M | 575.76M |
|
|
|||||
| Total Accounts Payable | 5.99M | 6.49M | 6.51M | 6.81M | 7.08M |
| Total Accrued Expenses | 34.87M | 26.53M | 23.78M | 16.00M | 33.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.11M | 12.85M | 12.42M | 9.89M | 6.35M |
| Total Finance Division Other Current Liabilities | 13.80M | 20.66M | 19.44M | 23.44M | 38.41M |
| Total Other Current Liabilities | 13.80M | 20.66M | 19.44M | 23.44M | 38.41M |
| Total Current Liabilities | 67.77M | 66.53M | 62.14M | 56.14M | 85.69M |
|
|
|||||
| Total Current Liabilities | 67.77M | 66.53M | 62.14M | 56.14M | 85.69M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 74.65M | 75.38M | 75.77M | 77.13M | 78.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 3.19M | 23.78M | 16.77M |
| Total Liabilities | 142.42M | 141.91M | 141.10M | 157.05M | 180.79M |
|
|
|||||
| Common Stock & APIC | 1.59B | 1.57B | 1.31B | 1.29B | 926.28M |
| Retained Earnings | -754.61M | -683.86M | -621.37M | -579.31M | -530.75M |
| Treasury Stock & Other | -1.49M | 1.93M | -2.10M | -1.78M | -552.00K |
| Total Common Equity | 835.62M | 892.93M | 684.92M | 711.20M | 394.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 835.62M | 892.93M | 684.92M | 711.20M | 394.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 835.62M | 892.93M | 684.92M | 711.20M | 394.97M |
|
|
|||||
